top of page

Eyes on Pharma
Check-out What Intel Caught our Eye

Robin Bateman
1 day ago2 min read
2025 FDA Approvals - January Approvals
Here at PharmaTell, we have Eyes on FDA Approvals for 2025. Below, we share the monthly Novel Drug and Biologic License Application Approval

Jana Chisholm
Jan 317 min read
JP Morgan Healthcare Conference Key Takes, and More
We've had Eye's On the JP Morgan Healthcare Conference, Lifesciences 2024 restructuring stats, and some new drug development partnerships.

Jana Chisholm
Jan 206 min read
BioPharma M&A Update
According to an annual PwC study released in December, the amount of M&A activity in the pharmaceutical and life sciences sectors in 2024...

Robin Bateman
Jan 27 min read
2024 FDA Approvals
Check out the final listings of FDA NDA and BLA approvals for 2024.

Jana Chisholm
Dec 11, 202416 min read
Eyes on 3Q24 Financial Results
We've highlighted a few firms: Lilly, AbbVie, Pfizer, Novo Nordisk, BMS, Roche, Novartis, Merck, AstraZeneca, GSK, Viatris, Teva, and Amgen.

Jana Chisholm
Nov 30, 20245 min read
Eyes On Alzheimer's, Epilepsy, Immunology, and Obesity
This week, we had eyes on data readouts, launch metrics, M&A, and more. Catch up with the news from Roche, AstraZeneca, Lundbeck, and AbbVie


Jana Chisholm
Nov 17, 20244 min read
Eyes on Sanofi, Regeneron, Novo Nordisk, and Pfizer
We've had Eyes On some of the recent deals, results, and investor actions. Check out the happenings at Sanofi/Opella, Pfizer, Regeneron, and

Jana Chisholm
Nov 1, 20245 min read
Eyes On October M&A activities, Approvals, and more
Last month, we had Eyes On some of the latest approvals, M&A and litigation. Read more about AbbVie, Genentech, Lundbeck, and GSK ...

Jana Chisholm
Oct 5, 20246 min read
Eyes on BMS, Pfizer, & Amgen
Eye's on the Amgen data releases for gMG & Atopic Dermatitis, the BMS approval of Cobenfy for schizophrenia, and Pfizer's Oxbryta recall...

Jana Chisholm
Sep 20, 20245 min read
Eyes on BioPharma Headlines
This month, we've had Eyes on investment trends, strategic restructuring, and FDA decisions. Fall seems to be gearing up, and we can't wait

Jana Chisholm
Sep 6, 20245 min read
August News Highlights
We've had our Eyes On some of the latest Pharmaceutical news including approvals, partnering, mergers, research programs, and

Jana Chisholm
Aug 11, 20246 min read
Eyes On Industry News & Views
News & Views - sharing some oncology, AZD, M&A tidbits that caught our eye.

Jana Chisholm
Jul 17, 20245 min read
Eyes On the Competition
his week we've been looking at the competition heating up due to a combination of M&A, biosimilar entrants, and new clinical data ...

Jana Chisholm
Jul 7, 20245 min read
Eyes on Oncology, Anti-Virals, and Consumer Products
We've had our Eyes On recent data releases, commercial strategy updates, and some FDA updates. What caught your Eye last week?

Jana Chisholm
Jun 18, 20243 min read
Eyes on ASCO 2024
The ASCO 2024 annual meeting took place from 31st May to 4th June. A number of firms presented data, and others used this as an opportunity

jroele
Jun 7, 20242 min read
Our Comments & Links on Top 4 Biggest Drugs in 2023
Check out this Top Drugs of 2023 list with links to interesting reports in PharmaTell Studio. Contact us for a trial.

Jana Chisholm
May 18, 20245 min read
Eyes on Pharma Restructures + Pfizer's Clinical SAE
We've had Eyes On recent news further clarifying company restructures. In the midst of refining pipelines, and cutting corporate spending ..

Jana Chisholm
May 2, 20244 min read
1Q24 BioPharma Deals & Raises
We've been keeping Eyes On Deals & Raises in the BioPharma sector for the first quarter of 2024. Things seem to be heating-up ...

Jana Chisholm
Apr 16, 20243 min read
Eyes on Corporate Restructuring
Lately we've been keeping Eyes On the corporate restructuring in the BioPharma sector. We've seen Big Pharma and BioTech refocusing ...

Jana Chisholm
Mar 24, 20244 min read
Eyes on Current Events - Deals, Approvals & Operations
We've been trying to keep up with current events - here's some of what we've hay Eyes On this week.
bottom of page